| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/28/2005 | CA2540195A1 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 04/28/2005 | CA2535043A1 Process for preparing polysaccharide-protein conjugate vaccines |
| 04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
| 04/27/2005 | EP1526171A1 Simultaneous stimulation and concentration of cells |
| 04/27/2005 | EP1525890A1 Protein-Proteophore complexes |
| 04/27/2005 | EP1525889A1 Liquid pharmaceutical composition containing an erythropoietin derivative |
| 04/27/2005 | EP1525884A1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 04/27/2005 | EP1525882A1 Administration form comprising an acid-labile active compound |
| 04/27/2005 | EP1525858A1 High viscosity liquid controlled delivery system |
| 04/27/2005 | EP1525478A2 SHIGA TOXIN B-SUBUNIT AS A VECTOR FOR TUMOR DIAGNOSIS AND DRUG DELIVERY TO GB sb 3 /sb EXPRESSING TUMORS |
| 04/27/2005 | EP1525246A2 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic applications thereof |
| 04/27/2005 | EP1525224A1 Hyaluronic acid derivatives |
| 04/27/2005 | EP1525002A1 Method for the synthesis of anthracycline-peptide conjugates |
| 04/27/2005 | EP1525000A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 04/27/2005 | EP1524999A1 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 04/27/2005 | EP1524998A1 Stable pharmaceutical composition comprising erythropoietin |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524987A1 Nasal peptide pharmaceutical formulation |
| 04/27/2005 | EP1524981A1 Sustained release formulations comprising lamotrigine |
| 04/27/2005 | EP1524979A2 New effector conjugates, process for their production and their pharmaceutical use |
| 04/27/2005 | EP1524975A1 Improved transdermal delivery system for the administration of rotigotine |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1524973A1 A pharmaceutical composition useful for treating chronic myeloid leukemia |
| 04/27/2005 | EP1524971A1 Improved transdermal delivery system |
| 04/27/2005 | EP1524969A2 Microcapsules with modified release of active principles with low solubility for oral delivery |
| 04/27/2005 | EP1524967A1 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation |
| 04/27/2005 | EP1524966A1 Taste masked oral composition of telithromycin |
| 04/27/2005 | EP1299083B1 Implantable low molecular weight cellulosic compositions |
| 04/27/2005 | EP1255445B1 Method of filtration of a dairy stream |
| 04/27/2005 | EP1253932B1 Botulinum toxin pharmaceutical compositions |
| 04/27/2005 | EP1217993B1 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 04/27/2005 | EP1150707B1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 04/27/2005 | EP1139974A4 Soy depigmenting and skin care compositions |
| 04/27/2005 | EP1121153B1 Site-specific labeling of disulfide-containing targeting vectors |
| 04/27/2005 | EP1105122B1 Pharmaceutical compositions containing lipase inhibitors |
| 04/27/2005 | EP1073470B1 Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
| 04/27/2005 | EP0979072B1 Transdermal device for the delivery of testosterone |
| 04/27/2005 | EP0939818B1 Recombinant toxin fragments |
| 04/27/2005 | CN1610695A Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 04/27/2005 | CN1610694A Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders |
| 04/27/2005 | CN1610564A Compositions and methods of using collajolie |
| 04/27/2005 | CN1610563A Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments |
| 04/27/2005 | CN1610560A Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 04/27/2005 | CN1610559A Prostaglandin composition for the treatment of erectile dysfunction |
| 04/27/2005 | CN1610558A Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification |
| 04/27/2005 | CN1610555A Eye drops |
| 04/27/2005 | CN1610550A Pharmaceutical formulations comprising an immune response modifier |
| 04/27/2005 | CN1610539A Pharmaceutical composition comprising a 5HT1 receptor agonist |
| 04/27/2005 | CN1610538A Microemulsion preconcentrate |
| 04/27/2005 | CN1610536A Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis |
| 04/27/2005 | CN1610506A Center-filled chewing gum containing calcium |
| 04/27/2005 | CN1608683A Prepn of anticoagulant insoluble silk protein material |
| 04/27/2005 | CN1608675A Medicine-carrying nanometer polymer particle and its prepn and use |
| 04/27/2005 | CN1608674A Compound froctose injection and its medicine use |
| 04/27/2005 | CN1198844C Process of high purity albumin production |
| 04/27/2005 | CN1198659C Medical preparation, its preparing method and use in preparing medicine for accelerating collagen regeneration |
| 04/27/2005 | CN1198655C Solid mixtures of cyclodextrins prep. via melt-extrusion |
| 04/27/2005 | CN1198654C Pharmaceutical complex |
| 04/27/2005 | CN1198652C Method for adding activated medicinal compounds into foundamental materials |
| 04/27/2005 | CN1198650C Ocular tension lowering composition for topical administration |
| 04/27/2005 | CN1198644C Human parathyroid hormone medicine composition |
| 04/27/2005 | CN1198643C Insulin preparations containing carbohydrates |
| 04/27/2005 | CN1198625C Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 04/27/2005 | CN1198623C Ciclesonide-containing aqueous pharmaceutical composition |
| 04/27/2005 | CN1198620C Clathrates of dehydroepindrosterone and corresponding pharmaceutical compositions |
| 04/27/2005 | CN1198616C Oral formulations for anti-tumor compounds |
| 04/27/2005 | CN1198615C Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts of hydrates |
| 04/27/2005 | CN1198611C Anti-bacterial medicinal compositions |
| 04/27/2005 | CN1198609C Use of taxiol stabilized by albumin in preparing medicine for treating body tumor and medicine obtained therefrom |
| 04/27/2005 | CN1198603C Spray liquid for forming bandage and drug delivery system |
| 04/27/2005 | CN1198600C Edible MCC/PGA coating composition |
| 04/27/2005 | CN1198598C Hydrophilic/lipophilic polymeric matrix dosage |
| 04/27/2005 | CN1198596C Sustained release formulations for 24 hours release of metoprolol |
| 04/27/2005 | CN1198592C Process for producing particles with converted amorphous and/or meta-stable drystalline region into crystalline state |
| 04/27/2005 | CN1198591C Bioenhanced formulations comprising eprosartan in oral dosage form |
| 04/27/2005 | CN1198590C Antibody and polyalkylene glycol-bonded liposome |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/27/2005 | CN1198588C Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it |
| 04/27/2005 | CN1198587C Tear-gland specific emulsion for local application to eye tissue |
| 04/27/2005 | CN1198586C Topical compositions for NSAI drug delivery |
| 04/27/2005 | CN1198585C Effervescent ointment for vagina and rectum administration and its prepn |
| 04/27/2005 | CN1198564C Cosmetic product |
| 04/27/2005 | CN1198563C Acidified composition for topical treatment of nail and skin conditions |
| 04/27/2005 | CN1198518C Composition comprising liquid absorbed on support based on precipitate silica |
| 04/26/2005 | US6884882 Introducing an acetylene group at the 5-position of 2'-deoxyuridine, and reacting the formed intermediate 2'-deoxyuridine having the acetylene group at the 5-position, with a benzyl azide derivative |
| 04/26/2005 | US6884874 Such as n-methyl-alanine derivatives; for preparing antibody/maytansinoid complexes |
| 04/26/2005 | US6884817 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases |
| 04/26/2005 | US6884797 Targeted oxidative therapeutic formulation |
| 04/26/2005 | US6884794 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 04/26/2005 | US6884792 Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions |
| 04/26/2005 | US6884789 Containing an unoxidized and/or an oxidized cyclodextrin groups integrated into the polymer backbone; used as a delivery vehicle of various therapeutic agents; oxidation, amination |
| 04/26/2005 | US6884778 Biocompatible macromers |
| 04/26/2005 | US6884773 Modified hemoglobins, including nitrosylhemoglobins, and uses thereof |
| 04/26/2005 | US6884768 Using taurine compound; adjust bioavailability; prevent, suppression damage to intestine mucous membrane |
| 04/26/2005 | US6884437 Administration form comprising an acid-labile active compound |
| 04/26/2005 | US6884433 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 04/26/2005 | US6884430 Formulation of stabilized cationic transfection agent(s) /nucleic acid particles |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | US6884288 A mixture comprising gum acacia, hydroxypropyl methylcellulose and propylene glycol plasticizer, forming a water solution to coat on drug tablets, food, and candy; long shelf life and low shipping costs |
| 04/26/2005 | US6883516 Preparing solution of first component in liquid component such that after volatilization of liquid by passing solution through flow passage while heating, aerosol is formed having predetermined particle size distribution of first component |